Opocrin is a constantly evolving company with steady turnover growth. In 2006 it reported a 30% increase in turnover compared to the previous year.
Under the control of the family Saetti - Bianchini, Opocrin’s development has enabled the company to invest in human resources and facilities to assure its growth and the continued excellence of the quality standards for which it is renowned worldwide. Numerous companies in Italy and abroad exploit Opocrin’s quality and professionalism.
Opocrin operates successfully in the USA, Europe and Asiaworldwide.
Opocrin’s plants have obtained approvals by the most important authorities such as FDA, PMDA, ANVISA, Health Canada, KFDA, SFDA.